Amanote Research

Amanote Research

    RegisterSign In

Innovation and Off‐label Use, the French Case and More

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.13993
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

June 4, 2019

Authors
Alain BraillonJoel Lexchin
Publisher

Wiley


Related search

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

Reasons for and Frequency of Off - Label Drug Use

Medicinski Pregled
Medicine
2015English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Off-Label Use of Medicinal Products - Legal Rules and Practices

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

Contrast Enhanced Ultrasound (CEUS) and Off-Label Use (In Children)

Ultraschall in der Medizin
MedicineNuclear MedicineRadiologyImaging
2012English

Off-Label Use of Approved Drugs: Therapeutic Opportunity and Challenges

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

Anti-Depressants and Children: Suicidality. Off-Label Use, and Trial Publication

Indiana Health Law Review
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy